Mycosis fungoides primary prevention: Difference between revisions

	Cutaneous T cell lymphoma Microchapters
Home
Patient Information
Overview
Classification Mycosis fungoides Sezary syndrome
Pathophysiology

Revision as of 20:30, 19 December 2018

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

There are no established measures for the primary prevention of mycosis fungoides.

There are no established measures for the primary prevention of mycosis fungoides.

@@ Line 4: / Line 4: @@
 ==Overview==
-There are no established measures for the primary prevention of [disease name].
+There are no established measures for the primary prevention of mycosis fungoides.
-OR
-There are no available vaccines against [disease name].
-OR
-Effective measures for the primary prevention of [disease name] include [measure1], [measure2], and [measure3].
-OR
-[Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include [strategy 1], [strategy 2], and [strategy 3].
 ==Primary Prevention==
-There are no established measures for the primary prevention of [disease name].
+There are no established measures for the primary prevention of mycosis fungoides.
-OR
-There are no available vaccines against [disease name].
-OR
-Effective measures for the primary prevention of [disease name] include:
-*[Measure1]
-*[Measure2]
-*[Measure3]
-OR
-[Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include:
-*[Strategy 1]
-*[Strategy 2]
-*[Strategy 3]
 ==References==